How does an economics theory apply to drug safety, and how can we use it to better manage rare, unexpected, and serious adverse drug reactions?

Perspective / 23 September 2024

Are you and your patient talking about the same thing when you discuss risk? Most likely not, and understanding this is key to effective risk communication.

Perspective / 18 March 2024

In this festive edition of Drug Safety Matters, we wrap up the year that was and look ahead to the year that will be – with a little help from one of our friends.

Perspective / 21 December 2023

Effective risk communication is a mainstay of successful pharmacovigilance, yet examples of poor risk mitigation abound. Where are we failing, and what can be done about it?

Perspective / 20 November 2023